Tenkasi

oritavancin (diphosphate) · Menarini International Operations Luxembourg S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tenkasi, covering 2024-11-20 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Tenkasi (previously Orbactiv) (oritavancin (diphosphate)) — Menarini International Operations Luxembourg S.A.